Senti Bio joins Cell & Gene Live cell therapy webinar

Senti Bio shared perspectives on how its Gene Circuit-based approach is designed to enable enhanced precision, control, and functionality in engineered cell therapies.

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Senti Biosciences, Inc., a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, announced that it participated in a Cell & Gene Live virtual event focused on emerging and enabling technologies designed to advance the development of innovative cell therapies.

Why it matters

The Cell & Gene Live webinar convened industry leaders and innovators to discuss approaches aimed at improving the design, development and translation of cell therapies, which is crucial for advancing more precise and effective therapeutic solutions for patients.

The details

During the event, Senti Bio shared perspectives on how its Gene Circuit-based approach is designed to enable enhanced precision, control, and functionality in engineered cell therapies, such as its Logic-Gated SENTI-202 product candidate.

  • The Cell & Gene Live webinar was held on February 19, 2026.

The players

Senti Biosciences, Inc.

A clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform.

Timothy Lu, MD, PhD

Co-Founder and CEO of Senti Biosciences.

Got photos? Submit your photos here. ›

What they’re saying

“We were thrilled to be invited to participate in this Cell & Gene Live event and to engage in a thoughtful discussion around cutting-edge technologies shaping the future of cell therapy development, such as our Logic-Gated SENTI-202 product.”

— Timothy Lu, Co-Founder and CEO (Cell & Gene Live)

“Forums like this are critical for sharing perspectives across the industry as we collectively work to advance more precise and effective therapeutic solutions for patients with our unique Logic-Gated cell therapies.”

— Timothy Lu, Co-Founder and CEO (Cell & Gene Live)

What’s next

A recording of the Cell & Gene Live event is available on demand and can be accessed on the event's website.

The takeaway

Senti Bio's participation in the Cell & Gene Live webinar highlights the company's commitment to advancing innovative cell therapy technologies that can improve the precision, control, and functionality of engineered cell therapies for the benefit of patients.